PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: air traffic controller

Merck & Co., Inc. - s21.q4cdn.com

As filed with the Securities and Exchange Commission on February 27, 2019 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D. C. 20549_____FORM 10-K(MARK ONE) Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2018or Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 1-6571_____Merck & Co., Galloping Hill RoadKenilworth, N. J. 07033(908) 740-4000 Incorporated in New EmployerIdentification No. 22-1918501 Securities Registered pursuant to Section 12(b) of the Act:Title of Each ClassName of Each Exchange on which RegisteredCommon Stock ($ par value)New York Stock Notes due 2021 New York Stock Notes due 2024 New York Stock Notes due 2026 New York Stock Notes due 2034 New York Stock Notes due 2036 New York Stock ExchangeNumber of shares of Common Stock ($ par value) outstanding as of January 31, 2019: 2,581,220, market value of Common Stock ($ par value) held by non-affiliates on June 30, 2018 based on closing price on June 30,2018: $161,991,000, by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Pharmaceutical. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment

Tags:

  Vaccine

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Merck & Co., Inc. - s21.q4cdn.com

Related search queries